.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A randomized controlled trial demonstrates that a structured music listening intervention significantly enhances quality of life and reduces symptom burden in patients suffering from rheumatoid arthritis, offering a low-cost, non-invasive complementary modality for clinical care.
GLP-1 receptor agonists provide anti-inflammatory and tissue-protective effects across osteoarthritis, rheumatoid arthritis, psoriatic disease, and lupus. Evidence supports their current clinical use in rheumatic patients with obesity, diabetes, or elevated cardiovascular risk.
Explore evidence on preclinical rheumatoid arthritis intervention. Understand how risk stratification tools, trial data, and individualized precision strategies balance preventive benefits against clinical risks in at-risk individuals.
T-cell engagers represent an off-the-shelf therapeutic breakthrough for rheumatic diseases. By redirecting endogenous T cells to deplete pathogenic B cells, they offer deep tissue clearance, manageable toxicity, and potential immune resetting without the manufacturing complexities of autologous CAR-T cell therapy.
Glucocorticoid management in rheumatic diseases requires balancing disease remission against drug toxicity. This review explores the 'Slay or Stay' debate across lupus, rheumatoid arthritis, and vasculitis, providing evidence-based tapering algorithms to optimize patient safety and prevent relapse.
